Summary & Overview
Bilateral or Multiple Major Joint Procedures of Lower Extremity with MCC: Inpatient Reimbursement Overview
DRG 461 pertains to bilateral or multiple major joint procedures of the lower extremity with a Major Complication or Comorbidity and encompasses more complex inpatient episodes. It matters for inpatient reimbursement because the Major Complication or Comorbidity status increases the Diagnosis-Related Group weight and corresponding Medicare payment to account for greater resource use.
DRG 461 Overview
DRG 461 covers bilateral or multiple major joint replacement procedures of the lower extremity when a Major Complication or Comorbidity is present. Typical cases involve simultaneous or staged replacement of hips or knees with significant medical or surgical complications that increase resource use. This Diagnosis-Related Group matters for Medicare payment because the presence of a Major Complication or Comorbidity elevates the relative weight and expected reimbursement to reflect higher inpatient resource consumption. Accurate assignment influences hospital payment and resource planning.
Clinical Trials
- Perioperative optimization and complication-reduction trials: Studies that test enhanced prehabilitation protocols, anesthesia techniques, blood management strategies, and infection-prevention bundles for patients undergoing bilateral or multiple major lower-extremity joint procedures with major complications (MCC). These trials enroll older adults and medically complex patients (eg, significant cardiac, pulmonary, renal comorbidities, or active infections) who are at high risk for perioperative morbidity, and evaluate endpoints such as rates of major adverse events, transfusion requirements, length of stay, and readmissions. Results inform surgeons, anesthesiologists, and hospital administrators about interventions that can reduce catastrophic complications and resource utilization in this high-cost DRG.
- Comparative effectiveness studies of surgical approaches and timing: Research comparing staged versus single-session bilateral joint replacement, different surgical approaches (eg, tissue-sparing versus standard exposure), or implant strategies in patients requiring multiple major lower-extremity joint procedures and presenting with MCC (such as sepsis, acute organ dysfunction, or severe perioperative infection). These trials or observational cohort studies focus on functional recovery, complication profiles, reoperation rates, and inpatient costs among subgroups defined by acuity and comorbidity burden, helping clinicians choose care pathways that balance short-term risk against long-term mobility outcomes. Payers and hospitals use these data to guide episode pricing, case selection, and policies about allowable inpatient care patterns for complex bilateral procedures.
- Post-discharge outcomes and care-coordination studies: Prospective studies and pragmatic trials evaluating post-acute care models (enhanced home-based rehabilitation, intensive skilled nursing protocols, or mobile monitoring) for survivors of bilateral/multiple lower-extremity joint surgery complicated by MCC, assessing functional recovery, long-term disability, readmission, and total 90–180 day costs. These studies target patients discharged with persistent organ dysfunction, wound issues, or mobility-limiting sequelae, and measure how different discharge strategies affect recovery trajectories and downstream utilization. Findings are critical for providers and payers to design effective transitional care bundles and to reduce costly readmissions and prolonged institutional post-acute stays in this vulnerable DRG cohort.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.